gene therapy at oxford university | the edge | cnbc international
Published 10 years ago • 2.3K plays • Length 4:40Download video MP4
Download video MP3
Similar videos
-
6:26
sangamo therapeutics ceo: alzheimer's and parkinson's gene therapies | mad money | cnbc
-
4:29
elevatebio ceo on disruptive potential for gene and cell therapies
-
5:23
china will continue to struggle with weak demand for the rest of the year: professor
-
5:20
'attractive' growth ahead for novo nordisk, ceo says
-
4:18
lumen ceo kate johnson: we're building the backbone of the ai economy
-
5:35
intellia ceo on crispr gene-editing treatment, secondary offering
-
4:49
recursion ceo on $688m exscientia acquisition: hope to bring better medicines to patients sooner
-
4:48
cisco to lay off thousands of more workers, reuters reports
-
6:04
a message from ark’s cio cathie wood
-
1:06:10
base editing with beam therapeutics ceo john evans
-
2:01
we see more opportunities in international markets, says thornburg's emily leveille
-
3:39
crispr therapeutics ceo: science in gene editing is moving at break-neck speed
-
3:23
former cea chair jason furman on the fed and recession risks
-
3:00
eli lilly is becoming the 'goat' of obesity, says bmo's evan seigerman
-
2:41
biomarin ceo: study results for hemophilia gene therapy are as 'good as we could hope'
-
4:50
the economy's trajectory is concerning, says ey-parthenon's gregory daco
-
4:30
why health care could drive the next wave of ai growth
-
4:20
economist weighs in on outlook for china exports
-
4:25
bluebird ceo defends $1.8 million price tag for gene therapy drug
-
1:48
the future of artificial intelligence | the edge
-
8:20
is the olympics clean? chinese swim team doping dispute, explained | abc news
-
2:13
genomic medicine continues to grow despite ethical concerns